FDA Approves Lupkynis (voclosporin) for Adult Patients with Active Lupus Nephritis

Article Link: FDA Approves Lupkynis (voclosporin) for Adult Patients with Active Lupus Nephritis

VICTORIA, British Columbia & ROCKVILLE, Md.– January 22, 2021 — Aurinia Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Lupkynis (voclosporin) in combination with a background…

Source: FDA New Drug Approvals